12:00 AM
 | 
Aug 06, 2012
 |  BC Week In Review  |  Company News  |  Other News

Shelbyzyme, Sanofi endocrine/metabolic news

A jury in the U.S. District Court for the District of Delaware ruled in favor of Shelbyzyme in a 2009 suit alleging that Fabry's disease therapy Fabrazyme...

Read the full 124 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >